Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vitrolife, a Sweden-based biomedical company, has received approval from the FDA for products within the fertility area used for the rapid freezing and thawing of cleavage embryos.
Subscribe to our email newsletter
The two vitrification products that Vitrolife has obtained approval for are RapidVit Cleave och RapidWarm Cleave. These two products, and two further vitrification products, RapidVit Blast och RapidWarm Blast (for rapid freezing and thawing of blastocysts, embryos on days five to seven after fertilization), have already been approved in Europe and Canada.
Nils Sellbom, director of marketing and sales at Vitrolife, said: “These are two very important products for us, as the majority of the clinics that freeze embryos do so at the very stage that the products are intended for, day three after fertilization.”